ARCHIVES

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million

March 5, 1999

NCI Conducting Four Epidemiology Studies On Radon

July 1, 1988

Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92

January 31, 2003

Duke Promised $11.5M For Eye, Lung Research.

March 8, 2002

Minimally Invasive Radiation Said To Preserve Functions

April 24, 2009